OUR GOVERNANCE

Committees of The Board

GOVERNING STRUCTURES AND DELEGATION - PRINCIPLES 6,7,8,9 & 10

Committees of the Board - Principle 8 Applied

The Board ensures that its arrangements for delegation within its own structures promote independent judgement and assists with the balance of power and the effective discharge of duties.

Board Committee Focus 2023 and Outlook for the Year Ahead 2024

Governance, Social and Ethics Committee

Declaration: The committee has executed its responsibilities in accordance with its Board approved mandate.

CHAIRPERSON - Gary Leong
Committee purpose and how it contributes to value creation

The overarching role of the Committee entails discharging its statutory duties by ensuring that the Company acts ethically and that there is an ethical culture with regards to:

  • Sustainable development
  • Corporate citizenship
  • Stakeholder relationships

The Committee relies on the work of the Human Resources and Remuneration Committee (“HRRC”) with respect to employment equity as well as the safety and the dignity of employees, and the Clinical Governance Committee (“CGC”) as regards the safety of employees and the provision of safe blood, ensuring that at least annually it obtains assurances from both committees that their respective responsibilities have been adequately addressed.

Members of the committee during the period 1 April 2022 to 31 March 2023
  • Gary Leong (Chairperson)
  • Ansie Ramalho
  • Thabo Mokgatlha
  • Lerato Molefe (from 19 November 2022)
  • Phindile Mthethwa
  • Brendan Damons (outside co-opted member)
  • Ravi Reddy (CEO)
Key focus areas and value-creating activities for the period under review
Ethics Management
  • Oversight and implementation of the Ethics Strategy Management Plan
  • Monitored progress to achieve objectives of the integrated Ethics and Culture Programme – including SANBS Code of Ethics (including recognising gender neutrality) and appointment of Ethics Ambassadors and consultants for the provision of Compliance and Ethics services
  • Oversight of the improvement in culture and organisational well-being and tracking of key metrics against targets
Reviewed governance documents and policies to continually improve and embed good governance and the structural arrangements that support it, including:
  • Whistleblowing Policy and Tip-Offs Report – including analysis of trends and mechanisms of addressing findings and implementing corrective actions
  • Anti-fraud and Anti-Corruption Policy and awareness training
  • Policy and Procedure Management Policy – defining strategic and operational type policies
  • Stakeholder Management Policy to embed a systematic approach to the management of stakeholder practices and processes to maximise value for stakeholders and SANBS
Gender classifications
  • Following gazetting of the new Code of Good Practice on the Prevention and Elimination of Harassment in the workplace. As an example - SANBS’ policies are being reviewed and amended to reflect gender neutral language
Stakeholder Management
  • Monitor progress with implementation of the SANBS Stakeholder engagement strategy - Stakeholder reports including consideration of stakeholder risks
Workplace/social and economic development/corporate citizenship
  • B-BBEE report and audit to retain level 4 rating
Social Environment/Corporate Citizenship
  • Considered feedback provided, in relation to donor committee activities. See stakeholder engagement
  • Branch and zone donor committee rules reviewed and updated following input provided by a broad range of affected stakeholders
  • Considered activities contributing to donations, charitable giving and socio-economic development
Future focus areas 2024
  • Adoption and oversight of the revised Ethics Strategy Management Plan/integrated Ethics and Culture Programme
  • Monitor outcomes of the SANBS stakeholder database review through the influence/power lens
  • Consider SANBS corporate citizenship contributions including the development of communities and environmental initiatives
Capitals
Stakeholders
King IVTM
Risks
Nomination Committee